Health sciences company PreveCeutical Medical (CSE: PREV)
(OTCQB: PRVCF) (FSE: 18H) this morning announced its entry into an agreement to
form a joint venture focused on the development of a range of medicinal
cannabinoid products, including sublingual tablets, transdermal patches and
other jointly evaluated products aimed at treating various ailments such as
chronic pain, inflammation, epilepsy and anxiety disorders. “This agreement
between PreveCeutical and Asterion further supports our mission to improve
global health and healthcare by utilizing innovative science and cutting-edge
technology to enhance natural products,” Stephen Van Deventer, chairman, CEO
and president of PreveCeutical, stated in the news release. “Our joint venture
with Asterion comes at an important time, using Asterion’s high quality, low
cost, genetically uniform strains of medicinal cannabis will allow
PreveCeutical to supply the anticipated increasing demand for effective and
personalised cannabis-based therapies.”
To view the full press release, visit http://ibn.fm/Z2XVz
About PreveCeutical Medical Inc.
PreveCeutical is a health sciences company that develops
innovative options for preventive and curative therapies utilizing organic and
nature identical products. PreveCeutical aims to be a leader in preventive
health sciences and currently has five research and development programs,
including: dual gene therapy for curative and prevention therapies for diabetes
and obesity; the Program; Nature Identical™ peptides for treatment of various
ailments; non-addictive analgesic peptides as a replacement to the highly
addictive analgesics such as morphine, fentanyl and oxycodone; and a
therapeutic product for treating athletes who suffer from concussions (mild
traumatic brain injury). PreveCeutical sells CELLB9®, an Immune System Booster.
CELLB9® is an oral solution containing polarized and potentiated essential
minerals extracted from a novel peptide obtained from Caribbean Blue Scorpion
venom. This product is available on the company’s website. For more
information, visit the company’s website at www.PreveCeutical.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and more,
these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment